{
  "docId": "019dd923-622c-750b-8b96-9677b0b52fc7",
  "docSlug": "1049581a951f",
  "documentTitle": "Prothena Corp PLC (PRTA)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2017-06-29 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 11,
  "pageCount": 11,
  "prevPage": 10,
  "nextPage": null,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "This is a research note page containing a transcript of an investor-CFO exchange.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b96-9677b0b52fc7/11",
  "deckHref": "/decks/019dd923-622c-750b-8b96-9677b0b52fc7",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b96-9677b0b52fc7.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b96-9677b0b52fc7#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.22,
        "w": 0.76,
        "x": 0.119,
        "y": 0.333
      },
      "kind": "list",
      "text": "Q: Okay. You know, we worked the data also and looking at the presentations of mean, like certainly made this kind of harder to really work out. Would you guys be able to provide data on a patient-by-patient basis, you know, with the response to the PCD therapy?\nMr. Nguyen: No. We haven't disclosed that information yet. We think we've shown it here. But I hear what you're saying, but we're not going to show that.\nQ: Okay. Why?\nMr. Nguyen: Because we're -- at this point, we would either show that in a publication -- you know, the KOLs and us worked it out. I don't personally know why the answer to that is, but we're not prepared to show it.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bad9c16-9feb-4436-84e0-b8b42cc77f74",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.76,
        "x": 0.119,
        "y": 0.272
      },
      "kind": "paragraph",
      "text": "An investor who recently spoke with PRTA's CFO found his tone in response to questions about releasing the individual patient trial data defensive, which could be an indicator that PRTA senior management is concerned about whether the data shows efficacy. Below is the exchange:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19a832c6-0a90-47df-88f0-9222e975275d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.76,
        "x": 0.119,
        "y": 0.581
      },
      "kind": "paragraph",
      "text": "When combining this reaction to PRTA insiders' consistent share selling (down to effectively no ownership) and the March 2017 equity issuance, we suspect insiders lack confidence in NEOD001's approval prospects.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6af9b9a-ff90-4169-8f19-6b28434ebe42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.76,
        "x": 0.119,
        "y": 0.147
      },
      "kind": "paragraph",
      "text": "Insiders seem to have voted on PRTA with their feet. Bloomberg shows that insiders currently own 0.04% of the shares (in addition to options). Also according to Bloomberg, since June 1, 2014, insiders have exercised options for 485,542 shares, and on the same days sold 478,876 of those shares.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e60b6d5d-9b9c-44b4-8357-df21b157a9d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.65,
        "x": 0.119,
        "y": 0.235
      },
      "kind": "title",
      "text": "Defensive Tone and Statements by CFO Support Our Concerns",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36b2e665-2797-4ce4-a27b-3a76fadca368",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "afef2960-b0ed-4250-b2b3-81238837dd76",
      "evidence": "The slide uses insider selling and defensive management behavior to argue for a lack of confidence in company prospects.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 10,
      "beatId": "f4c4ba81-826a-4154-aeba-186b18bb3adc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document concludes that NEOD001 is not efficacious, providing a solution to the problem",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}